Status: Recruiting
The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions
To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis with Hunner's lesions to reduce cicatricial changes in the bladder caused by electrocoagulation and to prevent secondary bladder shrinkage with a decrease in its volume.
Participants needed: 180
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: JSC NextGenUpdated: Mar 10, 2026Locations: 1
Eligibility criteria
Written informed consent prior to any study-related procedures. [+6]
Any condition that prevents intravesical administration of medications. [+14]